There are 2137 resources available
1325P - Long-term survival and health-related quality of life in patients treated with nivolumab for advanced non-small cell lung cancer: A wide prospective French real-world study (EVIDENS)
Presenter: Fabrice Barlesi
Session: E-Poster Display
Resources:
Abstract
1326P - Liver metastasis but not bone metastasis impact overall survival of advanced non-small cell lung cancer (NSCLC) treated by nivolumab (GFPC 04-2016)
Presenter: Chantal Decroisette
Session: E-Poster Display
Resources:
Abstract
1327P - Benchmarking the efficacy and safety of pembrolizumab plus chemotherapy to pembrolizumab monotherapy: A consecutive analysis of NSCLC patients with high PD-L1 expression
Presenter: Hiroshi Takumida
Session: E-Poster Display
Resources:
Abstract
1328P - Clinical outcomes of pembrolizumab plus chemotherapy in non-squamous metastatic NSCLC patients aged 75 years or older at US oncology practices
Presenter: Vamsidhar Velcheti
Session: E-Poster Display
Resources:
Abstract
1329P - Immune checkpoint inhibitors in advanced NSCLC patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers in a real world experience
Presenter: Riccardo Lobefaro
Session: E-Poster Display
Resources:
Abstract
1331P - Correlation between development and grade of immune-related toxicities and outcomes during treatment with immune checkpoint inhibitors in non-small cell lung cancer patients
Presenter: Pablo Ayala de Miguel
Session: E-Poster Display
Resources:
Abstract
1330P - Discontinuation of ICIs above 18 months of treatment in real-life patients with NSCLC: A multicentric retrospective study
Presenter: Geoffroy Bilger
Session: E-Poster Display
Resources:
Abstract
1332P - Prognostic value of baseline and dynamic change value of CTC in advanced NSCLC patients treated with immune checkpoint inhibitor-based therapy
Presenter: Guanghui Gao
Session: E-Poster Display
Resources:
Abstract
1333P - The influence of polypharmacy on outcome in real life non-small cell lung cancer (NSCLC) patients treated with immunotherapy
Presenter: Birgitte Bjoernhart
Session: E-Poster Display
Resources:
Abstract
1334P - Real word experience with first-line immunotherapy in advanced non-small cell lung cancer patients in a Danish nationwide cohort
Presenter: Mette Mouritzen
Session: E-Poster Display
Resources:
Abstract